Kuala Lumpur - Delayed Quote MYR

Pharmaniaga Berhad (7081.KL)

0.2650
-0.0150
(-5.36%)
At close: May 23 at 4:58:31 PM GMT+8
Loading Chart for 7081.KL
  • Previous Close 0.2800
  • Open 0.2750
  • Bid 0.2600 x --
  • Ask 0.2650 x --
  • Day's Range 0.2600 - 0.2850
  • 52 Week Range 0.2000 - 0.4700
  • Volume 2,796,200
  • Avg. Volume 2,903,964
  • Market Cap (intraday) 381.926M
  • Beta (5Y Monthly) 1.18
  • PE Ratio (TTM) 2.94
  • EPS (TTM) 0.0900
  • Earnings Date Aug 19, 2025 - Aug 25, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 8, 2022
  • 1y Target Est 0.39

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; and supply, trading, and installation of medical and hospital equipment. The company also manufactures and sells generic drugs; conducts research and development of pharmaceutical products; and manufactures, distributes, trades in, and sells food supplements. In addition, it distributes and trades in diagnostic products; and develops pharmacy management system for ordering management system, point-of-sale transactions, and inventory management. The company was founded in 1994 and is based in Shah Alam, Malaysia.

www.pharmaniaga.com

3,502

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 7081.KL

View More

Performance Overview: 7081.KL

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is FTSE Bursa Malaysia KLCI (^KLSE) .

YTD Return

7081.KL
25.35%
FTSE Bursa Malaysia KLCI (^KLSE)
6.51%

1-Year Return

7081.KL
25.35%
FTSE Bursa Malaysia KLCI (^KLSE)
5.76%

3-Year Return

7081.KL
61.47%
FTSE Bursa Malaysia KLCI (^KLSE)
0.46%

5-Year Return

7081.KL
32.47%
FTSE Bursa Malaysia KLCI (^KLSE)
6.86%

Compare To: 7081.KL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7081.KL

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    381.93M

  • Enterprise Value

    1.40B

  • Trailing P/E

    2.81

  • Forward P/E

    7.79

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.10

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.36

  • Enterprise Value/EBITDA

    5.13

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.53%

  • Return on Assets (ttm)

    7.91%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    3.85B

  • Net Income Avi to Common (ttm)

    135.76M

  • Diluted EPS (ttm)

    0.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    138.19M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    85.92M

Research Analysis: 7081.KL

View More

Company Insights: 7081.KL

Research Reports: 7081.KL

View More

People Also Watch